Skip to main content
logo
J-Pharma Co., Ltd. (TYO:520A)
Japan flag Japan · Delayed Price · Currency is JPY
274.00
-10.00 (-3.52%)
At close: Aug 26, 2026

J-Pharma Cash Flow Statement

Millions JPY. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024
Period Ending
Mar '26 Mar '25 Mar '24
Net Income
-2,466-1,499-1,652
Depreciation & Amortization
1.220.192.26
Asset Writedown & Restructuring Costs
7.73-11.1
Loss (Gain) on Equity Investments
6.01--
Stock-Based Compensation
302.0631.82269.64
Other Operating Activities
-504.43228.38-22.41
Change in Accounts Payable
77.85-38.62-88.61
Change in Income Taxes
34.29--
Change in Other Net Operating Assets
292.95-417.6369.05
Operating Cash Flow
-2,249-1,695-1,411
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024
Period Ending
Mar '26 Mar '25 Mar '24
Capital Expenditures
-4.02-0.19-2.22
Divestitures
9.44--
Sale (Purchase) of Intangibles
---11.13
Investment in Securities
-5.31--14.96
Other Investing Activities
-3.78--1.4
Investing Cash Flow
-3.67-0.19-29.71

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024
Period Ending
Mar '26 Mar '25 Mar '24
Issuance of Common Stock
4,3342,924925
Financing Cash Flow
4,3342,924925

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024
Period Ending
Mar '26 Mar '25 Mar '24
Foreign Exchange Rate Adjustments
69.36-0.271.94
Miscellaneous Cash Flow Adjustments
0-00
Net Cash Flow
2,1511,229-514.08

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024
Period Ending
Mar '26 Mar '25 Mar '24
Free Cash Flow
-2,253-1,695-1,414
Free Cash Flow Growth
---
Free Cash Flow Per Share
-178.18-208.12-225.48
Levered Free Cash Flow
-1,857-1,134-
Unlevered Free Cash Flow
-1,857-1,134-

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024
Period Ending
Mar '26 Mar '25 Mar '24
Cash Income Tax Paid
5.040.990.99
Change in Working Capital
405.09-456.25-19.56